High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
<h4>Unlabelled</h4>Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible reinfections were identified (confirmed reinfection...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69d3f6c371274168910dd797fe18d11d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:69d3f6c371274168910dd797fe18d11d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:69d3f6c371274168910dd797fe18d11d2021-11-18T08:47:51ZHigh rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.1932-620310.1371/journal.pone.0080216https://doaj.org/article/69d3f6c371274168910dd797fe18d11d2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24244654/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Unlabelled</h4>Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible reinfections were identified (confirmed reinfections were those genetically distinct from the previous infection and possible reinfections were used to define instances where genetic differences between infections could not be assessed due to lack of availability of hepatitis C virus sequence data). The incidence of confirmed reinfection was 28.8 per 100 person-years (PY), 95%CI: 15.0-55.4; the combined incidence of confirmed and possible reinfection was 24.6 per 100 PY (95%CI: 16.8-36.1). The hazard of hepatitis C reinfection was approximately double that of primary hepatitis C infection; it did not reach statistical significance in confirmed reinfections alone (hazard ratio [HR]: 2.45, 95%CI: 0.87-6.86, p=0.089), but did in confirmed and possible hepatitis C reinfections combined (HR: 1.93, 95%CI: 1.01-3.69, p=0.047) and after adjustment for the number of recent injecting partners and duration of injecting. In multivariable analysis, shorter duration of injection (HR: 0.91; 95%CI: 0.83-0.98; p=0.019) and multiple recent injecting partners (HR: 3.12; 95%CI: 1.08-9.00, p=0.035) were independent predictors of possible and confirmed reinfection. Time to spontaneous clearance was shorter in confirmed reinfection (HR: 5.34, 95%CI: 1.67-17.03, p=0.005) and confirmed and possible reinfection (HR: 3.10, 95%CI: 1.10-8.76, p-value=0.033) than primary infection. Nonetheless, 50% of confirmed reinfections and 41% of confirmed or possible reinfections did not spontaneously clear.<h4>Conclusions</h4>Hepatitis C reinfection and spontaneous clearance of hepatitis C reinfection were observed at high rates, suggesting partial acquired natural immunity to hepatitis C virus. Public health campaigns about the risks of hepatitis C reinfection are required.Rachel Sacks-DavisCampbell K AitkenPeter HiggsTim SpelmanAlisa E PedranaScott BowdenMandvi BharadwajUsha K NivarthiVijayaprakash SuppiahJacob GeorgeJason GrebelyHeidi E DrummerMargaret HellardPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e80216 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Rachel Sacks-Davis Campbell K Aitken Peter Higgs Tim Spelman Alisa E Pedrana Scott Bowden Mandvi Bharadwaj Usha K Nivarthi Vijayaprakash Suppiah Jacob George Jason Grebely Heidi E Drummer Margaret Hellard High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study. |
description |
<h4>Unlabelled</h4>Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible reinfections were identified (confirmed reinfections were those genetically distinct from the previous infection and possible reinfections were used to define instances where genetic differences between infections could not be assessed due to lack of availability of hepatitis C virus sequence data). The incidence of confirmed reinfection was 28.8 per 100 person-years (PY), 95%CI: 15.0-55.4; the combined incidence of confirmed and possible reinfection was 24.6 per 100 PY (95%CI: 16.8-36.1). The hazard of hepatitis C reinfection was approximately double that of primary hepatitis C infection; it did not reach statistical significance in confirmed reinfections alone (hazard ratio [HR]: 2.45, 95%CI: 0.87-6.86, p=0.089), but did in confirmed and possible hepatitis C reinfections combined (HR: 1.93, 95%CI: 1.01-3.69, p=0.047) and after adjustment for the number of recent injecting partners and duration of injecting. In multivariable analysis, shorter duration of injection (HR: 0.91; 95%CI: 0.83-0.98; p=0.019) and multiple recent injecting partners (HR: 3.12; 95%CI: 1.08-9.00, p=0.035) were independent predictors of possible and confirmed reinfection. Time to spontaneous clearance was shorter in confirmed reinfection (HR: 5.34, 95%CI: 1.67-17.03, p=0.005) and confirmed and possible reinfection (HR: 3.10, 95%CI: 1.10-8.76, p-value=0.033) than primary infection. Nonetheless, 50% of confirmed reinfections and 41% of confirmed or possible reinfections did not spontaneously clear.<h4>Conclusions</h4>Hepatitis C reinfection and spontaneous clearance of hepatitis C reinfection were observed at high rates, suggesting partial acquired natural immunity to hepatitis C virus. Public health campaigns about the risks of hepatitis C reinfection are required. |
format |
article |
author |
Rachel Sacks-Davis Campbell K Aitken Peter Higgs Tim Spelman Alisa E Pedrana Scott Bowden Mandvi Bharadwaj Usha K Nivarthi Vijayaprakash Suppiah Jacob George Jason Grebely Heidi E Drummer Margaret Hellard |
author_facet |
Rachel Sacks-Davis Campbell K Aitken Peter Higgs Tim Spelman Alisa E Pedrana Scott Bowden Mandvi Bharadwaj Usha K Nivarthi Vijayaprakash Suppiah Jacob George Jason Grebely Heidi E Drummer Margaret Hellard |
author_sort |
Rachel Sacks-Davis |
title |
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study. |
title_short |
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study. |
title_full |
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study. |
title_fullStr |
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study. |
title_full_unstemmed |
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study. |
title_sort |
high rates of hepatitis c virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/69d3f6c371274168910dd797fe18d11d |
work_keys_str_mv |
AT rachelsacksdavis highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT campbellkaitken highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT peterhiggs highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT timspelman highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT alisaepedrana highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT scottbowden highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT mandvibharadwaj highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT ushaknivarthi highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT vijayaprakashsuppiah highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT jacobgeorge highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT jasongrebely highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT heidiedrummer highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy AT margarethellard highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy |
_version_ |
1718421326080770048 |